Phillip G. Febbo - 02 Oct 2023 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Role: Chief Scientific & Med Officer
Signature: /s/ Jonathan Wygant, as attorney-in-fact
Issuer symbol: VCYT
Transactions as of: 02 Oct 2023
Net transactions value: $0
Form type: 4
Filing time: 04 Oct 2023, 16:35:03 UTC
Previous filing: 03 Mar 2023
Next filing: 08 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VCYT	Common Stock	Award	$0	+53,182		$0.000000	53,182	02 Oct 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VCYT	Stock Option (right to buy)	Award	$0	+85,858		$0.000000	85,858	02 Oct 2023	Common Stock	85,858	$21.96	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units awarded on October 2, 2023 vest 25% on December 2, 2024 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
F2	The option becomes exercisable as to 25% of the shares on October 2, 2024, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.